NCT04645810

A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence

A Pilot Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: University of Rochester · Academic / Other
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to learn more about what effects the use of high-dose-rate (HDR) brachytherapy on prostate cancer recurrence, seen by AXUMIN PET scan, has on prostate cancer.

Detailed description

In this study the investigator would like to better understand the use of high-dose rate (HDR) brachytherapy to target only recurrent prostate cancer that can be seen by AXUMIN PET scan. The use of HDR brachytherapy for prostate cancer is not new, but it is a more recent advancement to use it to treat only what can be seen instead of the whole prostate.

Conditions

• Prostate Cancer
• HDR

Interventions

Type	Name	Description
PROCEDURE	High-Dose-Rate Brachytherapy	High-Dose-Rate Brachytherapy Targeting only to AXUMIN PET Visible Lesion

Timeline

• Start date: 2021-10-29
• Primary completion: 2025-08-04
• Completion: 2025-08-04
• First posted: 2020-11-27
• Last updated: 2025-10-15

Locations

1 site across 1 country: United States